In conclusion, WSF might exert pharmacological effects against NAFLD by mediating activities of inflammatory related proteins of TLR4/NF-κB/COX-2 pathway, which would be verified in the subsequent experiments. This evidence concerns the gene PTGS2 and metabolic dysfunction-associated steatotic liver disease.